EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits

Hana Drobiova iD, Fahd Al-Mulla iD, Rabeah Al-Temaimi iD

Journal of Diabetes Research · 2025

DOI: 10.1155/jdr/5519447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Hana Drobiova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Kuwait University, Jabriya, Kuwait. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Membrane Proteins, ADAM Proteins, Metabolic Syndrome. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A disintegrin and metalloproteinase Domain 9 (ADAM9) is a zinc‐dependent proteinase involved in various biological processes. However, its role in the pathophysiology of metabolic syndrome remains unclear, and studies exploring the association between ADAM9 polymorphisms and metabolic traits are limited. In this study, we investigated the potential link between ADAM9 variants and metabolic syndrome traits in a cohort of adult participants from Kuwait. Using a genome‐wide association study (GWAS), followed by a replication study, we identified two ADAM9 variants—ADAM9‐E76K (rs61753672) and ADAM9‐P750L (rs144750648)—that were associated with various metabolic traits. The replication phase confirmed the association of ADAM9‐P750L with HbA1c levels and revealed new associations with systolic blood pressure, waist‐to‐hip ratio, fasting blood glucose, triglycerides, and cholesterol. Functional analysis showed that both variants exhibited reduced proteolytic activity, potentially contributing to the pathogenesis of Type 2 diabetes. These findings suggest that ADAM9 variants may play a significant role in metabolic health and diabetes risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Membrane ProteinsADAM ProteinsMetabolic SyndromePolymorphism, Single NucleotideHumansMaleMiddle AgedFemaleGenome-Wide Association StudyAdultBlood GlucoseGenetic Predisposition to DiseaseGlycated HemoglobinBlood Pressure

Stichwörter der Autor:innen

ADAM9SNPinsulin resistancemetabolic syndromepolymorphismvariants

Substanzen

Membrane ProteinsADAM9 protein, humanADAM ProteinsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, Kuwait University, Jabriya, Kuwait.
  • Translational Medicine Department, Dasman Diabetes Institute, Dasman, Kuwait.

ORCID-Profile: Hana Drobiova, Fahd Al-Mulla, Rabeah Al-Temaimi

Förderung

  • Kuwait University

Zitieren

APA

Drobiova, H., Al-Mulla, F., & Al-Temaimi, R. (2025). ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits. Journal of Diabetes Research. https://doi.org/10.1155/jdr/5519447

Vancouver

Drobiova H, Al-Mulla F, Al-Temaimi R. ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits. Journal of Diabetes Research. 2025. doi:10.1155/jdr/5519447

BibTeX
@article{Drobiova2025,
  author = {Drobiova, Hana and Al-Mulla, Fahd and Al-Temaimi, Rabeah},
  title = {ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits},
  journal = {Journal of Diabetes Research},
  year = {2025},
  doi = {10.1155/jdr/5519447}
}
Kostenlos starten →